If you haven't signed up for 2023 #ASPET meeting, poster abstract submission is still open until Dec 8!
Hope to see you in St. Louis
@ASPET#CancerPharmacology
Often I feel that science today focuses to much on what happens and not enough on why. Outcomes are important, but if we don't understand a system, trying to determine how to change the outcome seems like a tall order.
@ReliantGlyco has arrived at the @ASNKidney#KidneyWk 2022! If you are here, be sure to come by and say hello at booth 1324. We are so happy to be here and cannot wait to see everyone tomorrow!
#Glycinereceptors (GR) are promising targets for #paintherapies, via production of #antinociception. Three @Sydney_Uni authors discuss the structural basis for how current compounds cause positive allosteric modulation of GR. #PharmRev. More here: https://t.co/e7LPuiDkEU
Excited to announce Reliant has received a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase II award to continue the development of our IgAN biomarker tests! 🧪🧑🔬@nihseed@BioAlabama @UABInnovation
The CMTRA is honored to be having the 2022 Molecular Therapeutics of Cancer Research Conference in Stevenson, WA in July over the 17th – 21st, 2022. After 2 long years, we are excited to be back in person. We hope to see you there. Click here to register!
https://t.co/lLgSwwc2io
The UAB Medicine has been named a co-site on a $30 million National Institutes of Health grant to develop new or improved treatments for patients with glioblastoma, the most common and aggressive primary brain tumor in adults. Read more: https://t.co/puF4Y56jqi
@ONealCancerUAB
IgA Nephropathy is a disease that affects so many people in the world. This is why Reliant's primary focus is IgA Nephropathy. We are so happy to see young and motivated students present during this powerful week. Great discovery and presentation!
@MaryBun10#ASMS2021@UABSOM
Reliant's Team page had a facelift last week and upgraded the page's headshots. Check out the new members of Reliant as well as the new headshots for each member! We are very excited about the growth of our team and company happening over 2021. 📸
https://t.co/DseRZSjpN0